Development of PI3K inhibitors in breast cancer.

被引：0
|
作者：
Ma, Cynthia X. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA25
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [1] Clinical development of PI3K/AKT pathway inhibitors in breast cancer.
    Derynck, Mika
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 22 - 22
  • [2] PI3K inhibitors as a backbone for combination treatments for breast and ovarian cancer.
    Wulf, Gerburg
    Konstantinopoulos, Panos
    Barry, William
    Sonzongi, Olmo
    Eismann, Julia
    Kucherlapati, Bose
    Matulonis, Ursula
    [J]. MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 22 - 22
  • [3] PI3K Inhibitors in Breast Cancer Therapy
    Ellis, Haley
    Ma, Cynthia X.
    [J]. CURRENT ONCOLOGY REPORTS, 2019, 21 (12)
  • [4] PI3K Inhibitors in Breast Cancer Therapy
    Haley Ellis
    Cynthia X. Ma
    [J]. Current Oncology Reports, 2019, 21
  • [5] The Development of PI3K Pathway Modulators for Cancer.
    Sellers, W. R.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 484S - 484S
  • [6] Development and safety of PI3K inhibitors in cancer
    Miaomiao Yu
    Jiajia Chen
    Zhifei Xu
    Bo Yang
    Qiaojun He
    Peihua Luo
    Hao Yan
    Xiaochun Yang
    [J]. Archives of Toxicology, 2023, 97 : 635 - 650
  • [7] Development and safety of PI3K inhibitors in cancer
    Yu, Miaomiao
    Chen, Jiajia
    Xu, Zhifei
    Yang, Bo
    He, Qiaojun
    Luo, Peihua
    Yan, Hao
    Yang, Xiaochun
    [J]. ARCHIVES OF TOXICOLOGY, 2023, 97 (03) : 635 - 650
  • [8] PI3K/mTOR Inhibitors in the Treatment of Luminal Breast Cancer. Why, When and to Whom?
    Schettini, Francesco
    Buono, Giuseppe
    Trivedi, Meghana V.
    De Placido, Sabino
    Arpino, Grazia
    Giuliano, Mario
    [J]. BREAST CARE, 2017, 12 (05) : 290 - 294
  • [9] PI3K/Akt/mTOR inhibitors in breast cancer
    Lee, Joycelyn J. X.
    Loh, Kiley
    Yap, Yoon-Sim
    [J]. CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 342 - 354
  • [10] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    [J]. Cancer Biology & Medicine, 2015, (04) : 342 - 354
12345